C12Y 304/24014
Procollagen n-endopeptidase
Official title: Procollagen N-endopeptidase (3.4.24.14)
C12Y304/24014 (Procollagen n-endopeptidase) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 3
- Assignees
- 5
- Inventors
- 12
- Latest grant
- 14 Jul 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
By publication year.
Recent patents
- Compositions and methods for inhibiting expression of ADAMTS-5 and ADAM1714 Jul 2020US 10,709,729 B2Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
- Epigenetic biomarker ADAMTS9 for diagnosis and prognosis of gastric cancer24 Feb 2015US 8,962,236 B2The Chinese University of Hong Kong
- Cell-free animal collagen, methods of production and uses thereof5 Oct 2023US 2023/0312687 A1Aleph Farms Ltd.
- Compositions and methods for inhibiting expression of adamts-5 and adam176 Sep 2018US 2018/0250323 A1Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
- Epigenetic biomarker adamts9 for diagnosis and prognosis of gastric cancer18 Sep 2014US 2014/0274908 A1The Chinese University of Hong Kong
Most cited
By later US patents